Ann: September Quarterly Appendix 4C, page-7

"Cardiex Limited (ASX: CDX) (the Company) is pleased to announce pre-orders for the CONNEQT Arterial Health Assessment, which comes complete with the CONNEQT Pulse vascular biometric monitor, have commenced in the USA. Following a very successful waitlist campaign for the Pulse, which has seen more than 20,000 sign-ups, combined with a six-part nurturing campaign to this group, exclusive invitations for pre-orders have now commenced. This key milestone marks the first phase of the Company’s transition to delivering transformative cardiovascular solutions, based on our industry-leading vascular biomarker technology, across a broader range of healthcare markets."